IP Verse

Compositions For Treating Heartworm Infestation - EP2598151

The patent EP2598151 was granted to Ceva Sant Animale on Dec 26, 2018. The application was originally filed on Jul 29, 2011 under application number EP11743497A. The patent is currently recorded with a legal status of "Revoked".

EP2598151

CEVA SANT ANIMALE
Application Number
EP11743497A
Filing Date
Jul 29, 2011
Status
Revoked
Mar 11, 2022
Grant Date
Dec 26, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM ANIMAL HEALTH USASep 25, 2019D YOUNG -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4199569
INTERNATIONAL-SEARCH-REPORTEP0473223
INTERNATIONAL-SEARCH-REPORTUS5728719
INTERNATIONAL-SEARCH-REPORTWO03002102
OPPOSITIONEP0473223
OPPOSITIONWO0137811
OPPOSITIONWO03002102
OPPOSITIONWO03004059

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- CLARK JN et al., "Pharmacokinetics of [3H]‐ivermectin in the dog following oral administration of a beef‐based chewable formulation containing ivermectin alone or in combination with pyrantel pamoate", J Vet. Pharmacol. Therap, (19920000), vol. 15, pages 217 - 220, XP055635987
OPPOSITION- DAURIO CP et al., "Bioavailability of ivermectin administered orally to dogs", Veterinary Research Communications, (19920000), vol. 16, pages 125 - 130, XP055635986
OPPOSITION- FASSLER et al., "Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive Collies", J Am Vet Med Assn, (19910000), vol. 199, no. 4, pages 457 - 460, XP055635982
OPPOSITION- "Heartgard® (ivermectin)", Product label, (201812), XP055635949
OPPOSITION- "Heartgard® Plus (ivermectin/pyrantel)", Product label, (201812), XP055635961
OPPOSITION- MCCALL JW et al., "Ivermectin in heartworm prophylaxis: studies with experimentally induced and naturally acquired infections", Proceedings of the Heartworm Symposium, (19860000), pages 9 - 13, XP055636009
OPPOSITION- PULLIAM JD et al., "Investigating ivermectin toxicity in Collies", Veterinary Medicine, (19850000), pages 33, 36 - 40, XP055636020
OPPOSITION- MAEDA H et al., "Design of controlled -release formulation for Ivermectin Using Silicone", International Journal of Pharmaceutics, (20030000), vol. 261, no. 1-2, pages 9 - 19, XP002546838
OPPOSITION- HOPPER K et al., "Ivermectin Toxicity in 17 Collies", Journal of Veterinary Internal Medicine, (20020000), vol. 16, pages 89 - 94, XP055636016
OPPOSITION- CUNNINGHAM et al., "Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs", American Journal of Veterinary Research, US, (200609), vol. 67, no. 9, pages 1564 - 1569, XP008110845

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents